FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira Heparin Sodium in 5% Dextrose Injection Recall

Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100…

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Jul 16, 2014
Recall ID
D-1425-2014
Check your lot numberHow we source this data

Summary

Hospira recalled Heparin Sodium in 5% Dextrose Injection starting Jun 6, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1425-2014 on Jul 16, 2014. Reason: Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.

Product description

Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7793-62

Lot numbers, UPCs & expiration codes

Lot # 34-811-KL, 36-106-KL, 36-114-KL; Exp. 12/15; 36-101-KL, Exp. 12/15; 37-202-KL, Exp. 1/16; 38-302-KL, Exp. 2/16; 38-305-KL, Exp. 2/16

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1425-2014
Classification
Class II
Status
Terminated
Recall initiated
Jun 6, 2014
FDA report date
Jul 16, 2014
Quantity
142,152 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-1425-2014, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
68631
Address
275 N Field Dr
Code information
Lot # 34-811-KL, 36-106-KL, 36-114-KL; Exp. 12/15; 36-101-KL, Exp. 12/15; 37-202-KL, Exp. 1/16; 38-302-KL, Exp. 2/16; 38-305-KL, Exp. 2/16
Postal code
60045-2579
Report date
Jul 16, 2014
Product type
Drugs
Recall number
D-1425-2014
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
142,152 bags
Termination date
Apr 3, 2015
Reason for recall
Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7793-62
Distribution pattern
Nationwide
Recall initiation date
Jun 6, 2014
Initial firm notification
Letter
Center classification date
Jul 9, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1425-2014, published Jul 16, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls